Apart from aGvHD we also studied the GvT effect against the BCL1 lymphoma and performed a series of in vitro experiments to disect the responsiveness of CD4+ and CD8+ T cells toward Hsp90 inhibition. The gene discussed is CD4; the disease is lymphoma.